发明公开
EP1095932A1 PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
有权
PHENOXYESSIGSÄURE-VERBINDUNGEN UND MEDISINISCHE ZUSAMMENSETZUNGEN,DIEE ENTHALTEN
- 专利标题: PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
- 专利标题(中): PHENOXYESSIGSÄURE-VERBINDUNGEN UND MEDISINISCHE ZUSAMMENSETZUNGEN,DIEE ENTHALTEN
-
申请号: EP99926928.5申请日: 1999-07-05
-
公开(公告)号: EP1095932A1公开(公告)日: 2001-05-02
- 发明人: TANAKA, Nobuyuki , TAMAI, Tetsuro , MUKAIYAMA, Harunobu , HIRABAYASHI, Akihito, Haitsu Kashiwabara A106 , MURANAKA, Hideyuki, Rasukasasu Azumino 305 , SATO, Masaaki , AKAHANAE, Masuo
- 申请人: Kissei Pharmaceutical Co., Ltd.
- 申请人地址: 19-48, Yoshino Matsumoto-shi Nagano 399-8710 JP
- 专利权人: Kissei Pharmaceutical Co., Ltd.
- 当前专利权人: Kissei Pharmaceutical Co., Ltd.
- 当前专利权人地址: 19-48, Yoshino Matsumoto-shi Nagano 399-8710 JP
- 代理机构: Baverstock, Michael George Douglas
- 优先权: JP22850198 19980708
- 国际公布: WO0002846 20000120
- 主分类号: C07C217/60
- IPC分类号: C07C217/60 ; C07C255/59 ; C07C235/60 ; C07C233/43 ; C07C235/06 ; A61K31/215 ; A61K31/195
摘要:
The present invention provides novel phenoxyacetic acid derivatives represented by the general formula:
[wherein R 1 represents a hydroxy group, a lower alkoxy group, an aralkoxy group, an amino group, or a mono or di(lower alkyl)amino group; one of R 2 and R 3 is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, while the other is a hydrogen atom; R 4 represents a halogen atom, a lower alkyl group, a halo(lower alkyl)group, a hydroxy group, a lower alkoxy group, an aralkoxy group, a cyano group, a nitro group, an amino group, a mono or di(lower alkyl)amino group, a carbamoyl group, a mono or di(lower alkyl)carbamoyl group or a group represented by the general formula:
-NHCOR 5
(wherein R 5 represents a hydrogen atom or a lower alkyl group); the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration] and pharmaceutically acceptable salts thereof, which have excellent β 3 -adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.
[wherein R 1 represents a hydroxy group, a lower alkoxy group, an aralkoxy group, an amino group, or a mono or di(lower alkyl)amino group; one of R 2 and R 3 is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, while the other is a hydrogen atom; R 4 represents a halogen atom, a lower alkyl group, a halo(lower alkyl)group, a hydroxy group, a lower alkoxy group, an aralkoxy group, a cyano group, a nitro group, an amino group, a mono or di(lower alkyl)amino group, a carbamoyl group, a mono or di(lower alkyl)carbamoyl group or a group represented by the general formula:
-NHCOR 5
(wherein R 5 represents a hydrogen atom or a lower alkyl group); the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration] and pharmaceutically acceptable salts thereof, which have excellent β 3 -adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.
公开/授权文献
信息查询